NEW

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

NEC Releases ‘WISE VISION Endoscopy’ in Europe and Japan

NEC Corporation has announced the development of “WISE VISION Endoscopy,” an AI diagnosis-support medical device software for colonoscopies, which is being released in Japan and is expected to soon be available in Europe.

Tibial Distractor Provides Distraction with Rotation for Axial Alignment

The Tibial Distractor from Innovative Medical Products simplifies tibial surgical procedures by providing distraction with rotation for axial alignment without need for a second pair of hands, reducing radiation exposure to an assistant and the surgeon. The IMP solution also eliminates lengthy, fracture table set-up time and is autoclavable for multiple cases.

For use with intramedullary nailing, plating and bone grafting, IMP’s positioner aids in tibial nailing. The Tibial Distractor’s sterile protective pads are latex-free, foam pads that protect the patient from skin irritation, pressure sores and possible neurological damage. The pads are also compatible with the De Mayo Steri-Post.

To learn, visit innovativemedical.com/products/tibial.html.

 

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X